Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 242 | $198,543,761 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 19 Nov 2024 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Chief Scientific Officer | 15 Nov 2024 | Sale | 15 | 478.56 | 7,178 | D |
| 13 Nov 2024 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 11 Nov 2024 | Sale | 3,000 | 518.27 | 1,554,810 | D |
| 12 Nov 2024 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 08 Nov 2024 | Sale | 15,198 | 515 | 7,826,970 | D |
| 03 Oct 2024 16:12 | VRTX | VERTEX PHARMACEUTICALS INC | BILLER JONATHAN | EVP and Chief Legal Officer | 02 Oct 2024 | Sale | 999 | 461.66 | 461,198 | D |
| 04 Sep 2024 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 30 Aug 2024 | Sale | 3,784 | 499 | 1,888,216 | D |
| 04 Sep 2024 16:12 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 30 Aug 2024 | Sale | 646 | 500 | 323,000 | D |
| 12 Aug 2024 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 08 Aug 2024 | Sale | 1,292 | 466.29 | 602,447 | D |
| 08 Aug 2024 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 07 Aug 2024 | Sale | 2,280 | 476.75 | 1,086,990 | D |
| 02 Aug 2024 16:10 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 01 Aug 2024 | Sale | 5,295 | 508 | 2,689,860 | D |
| 01 Aug 2024 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 30 Jul 2024 | Sale | 15,202 | 505 | 7,677,010 | D |
| 25 Jul 2024 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 24 Jul 2024 | Sale | 2,280 | 488.46 | 1,113,689 | D |
| 24 Jul 2024 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 22 Jul 2024 | Sale | 15,202 | 497 | 7,555,394 | D |
| 12 Jul 2024 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 10 Jul 2024 | Sale | 2,280 | 487.34 | 1,111,135 | D |
| 28 Jun 2024 16:04 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 26 Jun 2024 | Sale | 2,280 | 471.72 | 1,075,522 | D |
| 13 Jun 2024 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 12 Jun 2024 | Sale | 2,280 | 478 | 1,089,840 | D |
| 13 Jun 2024 16:09 | VRTX | VERTEX PHARMACEUTICALS INC | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 12 Jun 2024 | Sale | 7,288 | 478 | 3,483,664 | D |
| 05 Jun 2024 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 03 Jun 2024 | Sale | 3,250 | 460 | 1,495,000 | D |
| 05 Jun 2024 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 03 Jun 2024 | Sale | 2,175 | 460 | 1,000,500 | D |
| 03 Jun 2024 16:09 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 31 May 2024 | Sale | 2,250 | 445 | 1,001,250 | D |
| 03 Jun 2024 16:09 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 30 May 2024 | Sale | 2,350 | 439.11 | 1,031,908 | D |
| 31 May 2024 16:19 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 29 May 2024 | Sale | 2,280 | 445.56 | 1,015,877 | D |
| 30 May 2024 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 28 May 2024 | Sale | 3,250 | 454.79 | 1,478,068 | D |
| 29 May 2024 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 24 May 2024 | Sale | 1,565 | 457 | 715,205 | D |
| 24 May 2024 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 22 May 2024 | Sale | 7,073 | 448 | 3,168,704 | D |
| 22 May 2024 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 20 May 2024 | Sale | 15,202 | 447 | 6,795,294 | D |
| 17 May 2024 16:27 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 15 May 2024 | Sale | 32 | 430.93 | 13,790 | D |
| 17 May 2024 16:24 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 May 2024 | Sale | 69 | 430.93 | 29,734 | D |
| 17 May 2024 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Chief Scientific Officer | 15 May 2024 | Sale | 54 | 430.93 | 23,270 | D |
| 03 May 2024 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2024 | Sale | 467 | 402.95 | 188,178 | D |
| 03 Apr 2024 16:02 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 02 Apr 2024 | Sale | 240 | 419 | 100,560 | D |
| 27 Feb 2024 17:02 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 26 Feb 2024 | Sale | 354 | 425.7 | 150,698 | D |
| 27 Feb 2024 16:59 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 26 Feb 2024 | Sale | 3,004 | 425.7 | 1,278,803 | D |
| 27 Feb 2024 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 26 Feb 2024 | Sale | 883 | 425.7 | 375,893 | D |
| 27 Feb 2024 16:37 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 26 Feb 2024 | Sale | 5,034 | 425.7 | 2,142,974 | D |
| 27 Feb 2024 16:29 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 26 Feb 2024 | Sale | 883 | 425.7 | 375,893 | D |
| 27 Feb 2024 16:24 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 26 Feb 2024 | Sale | 4,239 | 425.7 | 1,804,542 | D |
| 23 Feb 2024 16:28 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 21 Feb 2024 | Sale | 360 | 421.77 | 151,837 | D |
| 23 Feb 2024 16:20 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 21 Feb 2024 | Sale | 3,191 | 421.77 | 1,345,868 | D |
| 23 Feb 2024 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 21 Feb 2024 | Sale | 1,201 | 421.77 | 506,546 | D |
| 23 Feb 2024 16:12 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 21 Feb 2024 | Sale | 3,603 | 421.77 | 1,519,637 | D |
| 23 Feb 2024 16:10 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2024 | Sale | 3,002 | 421.77 | 1,266,154 | D |
| 21 Feb 2024 16:43 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 20 Feb 2024 | Sale | 480 | 420.79 | 201,979 | D |
| 21 Feb 2024 16:38 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 20 Feb 2024 | Sale | 4,254 | 420.79 | 1,790,041 | D |
| 21 Feb 2024 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 20 Feb 2024 | Sale | 801 | 420.79 | 337,053 | D |
| 21 Feb 2024 16:19 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 20 Feb 2024 | Sale | 4,804 | 420.79 | 2,021,475 | D |
| 21 Feb 2024 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 20 Feb 2024 | Sale | 4,002 | 420.79 | 1,684,002 | D |
| 16 Feb 2024 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 15 Feb 2024 | Sale | 4,655 | 419.16 | 1,951,190 | D |
| 16 Feb 2024 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 14 Feb 2024 | Sale | 4,356 | 419.04 | 1,825,338 | D |
| 14 Feb 2024 16:04 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 13 Feb 2024 | Sale | 737 | 419.13 | 308,899 | D |
| 14 Feb 2024 16:04 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 12 Feb 2024 | Sale | 647 | 420.39 | 271,992 | D |
| 14 Feb 2024 16:04 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 12 Feb 2024 | Sale | 2,009 | 419.22 | 842,213 | D |
| 13 Feb 2024 17:23 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 12 Feb 2024 | Sale | 314 | 420.24 | 131,955 | D |
| 13 Feb 2024 17:15 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 12 Feb 2024 | Sale | 3,222 | 420.24 | 1,354,013 | D |
| 13 Feb 2024 16:56 | VRTX | VERTEX PHARMACEUTICALS INC | BILLER JONATHAN | EVP and Chief Legal Officer | 12 Feb 2024 | Sale | 1,738 | 418.77 | 727,822 | D |
| 13 Feb 2024 16:54 | VRTX | VERTEX PHARMACEUTICALS INC | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 12 Feb 2024 | Sale | 913 | 420.24 | 383,679 | D |
| 13 Feb 2024 16:51 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 12 Feb 2024 | Sale | 4,295 | 420.24 | 1,804,931 | D |
| 13 Feb 2024 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 12 Feb 2024 | Sale | 1,374 | 420.24 | 577,410 | D |
| 13 Feb 2024 16:46 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 12 Feb 2024 | Sale | 3,145 | 420.24 | 1,321,655 | D |
| 10 Jan 2024 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 08 Jan 2024 | Sale | 6,648 | 419.07 | 2,785,977 | D |
| 04 Jan 2024 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 Jan 2024 | Sale | 3,000 | 405 | 1,215,000 | D |
| 19 Dec 2023 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 15 Dec 2023 | Sale | 17,135 | 407 | 6,973,945 | D |
| 15 Dec 2023 16:33 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 13 Dec 2023 | Sale | 100 | 400.19 | 40,019 | D |
| 15 Dec 2023 16:33 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 13 Dec 2023 | Sale | 13,254 | 399.41 | 5,293,780 | D |
| 15 Dec 2023 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 13 Dec 2023 | Sale | 5,098 | 397 | 2,023,906 | D |
| 15 Dec 2023 16:20 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 13 Dec 2023 | Sale | 8,603 | 399 | 3,432,597 | D |
| 21 Nov 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 20 Nov 2023 | Sale | 3,000 | 349.88 | 1,049,640 | D |
| 17 Nov 2023 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 15 Nov 2023 | Sale | 35 | 369.92 | 12,947 | D |
| 17 Nov 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 15 Nov 2023 | Sale | 19 | 369.92 | 7,028 | D |
| 16 Nov 2023 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 14 Nov 2023 | Sale | 5,650 | 380.82 | 2,151,633 | D |
| 15 Nov 2023 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 13 Nov 2023 | Sale | 5,097 | 377 | 1,921,569 | D |
| 08 Nov 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 06 Nov 2023 | Sale | 11,250 | 385 | 4,331,250 | D |
| 02 Nov 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 31 Oct 2023 | Sale | 5,651 | 355.92 | 2,011,304 | D |
| 19 Oct 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 17 Oct 2023 | Sale | 5,651 | 373.25 | 2,109,236 | D |
| 19 Oct 2023 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 17 Oct 2023 | Sale | 243 | 375 | 91,125 | D |
| 18 Oct 2023 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 16 Oct 2023 | Sale | 12,962 | 374 | 4,847,788 | D |
| 11 Oct 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 06 Oct 2023 | Sale | 242 | 360 | 87,120 | D |
| 05 Oct 2023 16:30 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 03 Oct 2023 | Sale | 5,651 | 345.28 | 1,951,177 | D |
| 03 Oct 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BILLER JONATHAN | EVP and Chief Legal Officer | 02 Oct 2023 | Sale | 610 | 346.76 | 211,524 | D |
| 21 Sep 2023 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 19 Sep 2023 | Sale | 5,651 | 351 | 1,983,501 | D |
| 07 Sep 2023 16:29 | VRTX | VERTEX PHARMACEUTICALS INC | BOZIC CARMEN | EVP and CMO | 05 Sep 2023 | Sale | 5,651 | 352.66 | 1,992,882 | D |
| 25 Aug 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 23 Aug 2023 | Sale | 2,500 | 355 | 887,500 | D |
| 14 Aug 2023 16:09 | VRTX | VERTEX PHARMACEUTICALS INC | KEARNEY TERRENCE C | Director | 10 Aug 2023 | Sale | 10,000 | 350 | 3,500,000 | D |
| 14 Aug 2023 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 10 Aug 2023 | Sale | 5,750 | 345.79 | 1,988,293 | D |
| 14 Aug 2023 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SACHDEV AMIT | EVP, Chief Patient Officer | 10 Aug 2023 | Sale | 10,031 | 350 | 3,510,850 | D |
| 11 Aug 2023 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 09 Aug 2023 | Sale | 63 | 345.51 | 21,767 | D |
| 11 Aug 2023 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 09 Aug 2023 | Sale | 242 | 345.51 | 83,613 | D |
| 18 Jul 2023 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 17 Jul 2023 | Sale | 3,842 | 357.29 | 1,372,708 | D |
| 18 Jul 2023 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 17 Jul 2023 | Sale | 5,711 | 356.75 | 2,037,399 | D |
| 18 Jul 2023 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 17 Jul 2023 | Sale | 1,697 | 355.54 | 603,351 | D |
| 18 Jul 2023 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 17 Jul 2023 | Sale | 7,828 | 355 | 2,778,940 | D |
| 20 Jun 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Jun 2023 | Sale | 8,603 | 349 | 3,002,447 | D |
| 01 Jun 2023 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 30 May 2023 | Sale | 82 | 329.82 | 27,045 | D |
| 01 Jun 2023 16:12 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 30 May 2023 | Sale | 289 | 329.82 | 95,318 | D |
| 09 May 2023 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 08 May 2023 | Sale | 2,850 | 350 | 997,500 | D |
| 09 May 2023 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 05 May 2023 | Sale | 422 | 350.03 | 147,713 | D |
| 09 May 2023 16:10 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 08 May 2023 | Sale | 1,125 | 349 | 392,625 | D |
| 09 May 2023 16:10 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 05 May 2023 | Sale | 171 | 350.3 | 59,901 | D |
| 09 May 2023 16:10 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 05 May 2023 | Sale | 708 | 349.38 | 247,361 | D |
| 04 May 2023 16:51 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 03 May 2023 | Sale | 728 | 351.6 | 255,965 | D |
| 04 May 2023 16:51 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 03 May 2023 | Sale | 2,053 | 350.44 | 719,453 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)